Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Influenza Treatment Market In 2029?

In recent times, the influenza treatment market has been experiencing consistent growth. The market size is set to increase from $6.6 billion in 2024 to $6.9 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.5%. The expansion during the historical period can be tied back to the rise in the annual cases of influenza, augmented government spending on influenza research and readiness initiatives, campaigns to raise public awareness about vaccination, the creation of worldwide influenza tracking systems, and the escalation in healthcare facilities.

What Growth Rate Is Forecasted for the Influenza Treatment Market by 2029?

In the upcoming years, a consistent growth is anticipated for the influenza treatment market, with its size expected to reach $8.16 billion in 2029, growing at a compound annual growth rate (CAGR) of 4.3%. The projected market growth in this period can be ascribed to the emergence of novel antiviral medications and treatment approaches, broadening vaccination schemes, consistent enhancement and growth of healthcare systems, a rising older demographic, and the creation of new treatments. Key trends for the forecast period encompass strides made toward the development of universal vaccines, advancements in vaccine delivery mechanisms, the incorporation of AI and big data, progress in personalized medicine, and increased partnerships among pharmaceutical firms.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15832&type=smp

Which Key Companies Are Shaping the Future of the Influenza Treatment Market?

Major companies operating in the influenza treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Fujifilm Holdings Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd., Janssen Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited., Chugai Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Limited, NATCO Pharma Limited, BioCryst Pharmaceuticals Inc., NanoViricides Inc.

Which Factors Are Driving Demand in the Influenza Treatment Industry?

The surge in the frequency of communicable respiratory diseases is likely to boost the influenza treatment market in the future. Communicable respiratory disease refers to an infectious ailment like influenza, measles, or respiratory syncytial virus (RSV) infections, which are spread through interaction with an infected person, their bodily fluids, or through contaminated surfaces or items. Amplified population densities, inferior healthcare infrastructure, antibiotic misuse, and simplicity in international travel are factors contributing to the proliferation of these infectious respiratory diseases. Influenza treatment involves antiviral medications and vaccinations for various communicable respiratory diseases, including flu, COVID-19, and other respiratory viruses. For example, according to data from the Centers for Disease Control and Prevention (CDC), a US-based public health organization, the hospitalization rate related to RSV (Respiratory Syncytial Virus) spiked from 2 hospitalizations per 100,000 people in the week ending on August 5, 2023, to 7 hospitalizations per 100,000 individuals by the week ending on August 19, 2023. Therefore, the escalating occurrence of communicable respiratory diseases is stimulating the expansion of the influenza treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15832&type=smp

How Is the Influenza Treatment Market Segmented by Several Divisions?

The influenza treatment market covered in this report is segmented –

1) By Product Type: Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, Other Products

2) By Route Of Administration: Oral, Other Routes Of Administration

3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Other Distribution Channels

Subsegments:

1) By Peramivir: Intravenous Peramivir, Peramivir Injection

2) By Zanamivir: Inhaled Zanamivir, Zanamivir Diskhaler

3) By Oseltamivir Phosphate: Oseltamivir Capsules, Oseltamivir Oral Suspension

4) By Baloxavir Marboxil: Baloxavir Tablets, Baloxavir Granules For Oral Suspension

5) Other Products: Rimantadine, Amantadine

What are the Emerging Market Trends Driving the Growth of the Influenza Treatment Industry?

Major firms active in the influenza treatment market are concentrated on diversifying their product range by introducing novel solutions such as single-dose oral medication for influenza treatment, to improve patient adherence, enhance treatment results, and secure a larger market portion. A single-dose oral medication is a treatment specifically created to combat the flu with just one oral dose, hence simplifying the treatment protocol. For example, in August 2022, Genentech Inc., a biotechnology firm based in the USA, declared its approval by the U.S. Food and Drug Administration (FDA) for Xofluza (Baloxavir Marboxil). Xofluza is the first of its kind, a single-dose oral medicine that provides an easy and effective way to manage acute uncomplicated influenza in children aged five to under 12 years who’ve shown symptoms for no more than 48 hours and other respiratory viruses.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

Which Regions Are Driving Growth in the Influenza Treatment Market?

North America was the largest region in the influenza treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15832

This Report Delivers Insight On:

1. How big is the influenza treatment market, and how is it changing globally?

2. Who are the major companies in the influenza treatment market, and how are they performing?

3. What are the key opportunities and risks in the influenza treatment market right now?

4. Which products or customer segments are growing the most in the influenza treatment market?

5. What factors are helping or slowing down the growth of the influenza treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model